• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problems Erythema (1840); Pain (1994); Swelling/ Edema (4577)
Event Date 04/20/2024
Event Type  Injury  
Event Description
My doctor gave me the three shots of euflexxa.My knee turned very red and swollen and hot.I was in a lot of pain.Now my knee hurts worse than before i had the treatment.Reference reports: mw5154367, mw5154369.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
MDR Report Key19204054
MDR Text Key341433322
Report NumberMW5154368
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/26/2024
Patient Sequence Number1
Treatment
THYROID.; VITAMINS.
Patient Outcome(s) Other;
Patient Age73 YR
Patient SexFemale
Patient Weight67 KG
-
-